08/25/2020 - 10:57
- Clarín.com
- Society
The Oxford University vaccine against the coronavirus, which will be manufactured in Argentina, continues to advance and as the days go by, details are also known that not everyone knew. This Tuesday, in this regard, the Argentine doctor Marta Cohen , who works in England, revealed that this vaccine would give immunity only "for six months . "
"If we have the vaccine, you will be protected perhaps for six months, but if later you do not have the vaccine (again) you will become infected again , and that will continue as long as this virus continues to exist," explained the Hospital pediatric pathologist of Children of the British city of Sheffield in dialogue with CNN Radio .
On that issue, he recalled that flu vaccines "last a year" and that "most likely" is that the antidote against the coronavirus "lasts a short time."
"In fact, to reinforce this the group from Oxford and AstraZeneca said that the objective was to achieve six months of defense . Not even the same researchers were waiting more than six months," he said.
Marta Cohen, an Argentine doctor who works in Sheffield.
For Cohen, what we will have to wait is that "the virus will attenuate and disappear over the years", something that "will not be immediate". But in the meantime, "people are going to have to get vaccinated every six months ." And he reiterated that "two doses" must be given to achieve immunization.
He also clarified that phase 3 of the tests would end in September and "the analyzes for November" and that only then would it be known how long the vaccine would give immunity.
Finally, Cohen said that although several strains of the virus were identified, "so far the teams work with only one type of vaccine because the virus has mutated and produced different strains that would produce different types of symptoms, but the antigenic profile would be the same".
"So far they do not seem to require more than one vaccine," he concluded.
The mAbxience laboratory that will produce in the country the "active substance" of the Oxford University vaccine. Photo Maxi Failla
It emerged on Tuesday that the experimental Covid-19 vaccine being developed by the University of Oxford and AstraZeneca could be presented to regulators this year if scientists can collect enough data. This was stated by the director of the Oxford Vaccine Group.
"It is possible that if the cases accumulate quickly in clinical trials, we could have that data before the regulators this year, and then there would be a process that they would go through to do a full evaluation of the data," Andrew Pollard told the BBC. .
The vaccine will be manufactured in Argentina and Mexico, following an agreement between private parties and national governments, and then distributed to the rest of the region.
PJB